By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CeloNova BioSciences 

18615 Tuscany Stone
Suite 100
San Antonio   Texas  78258  U.S.A.
Phone: 210-489-4000 Fax: 210-403-2008


SEARCH JOBS


Industry
Medical Device






Company News
CeloNova BioSciences’s Coronary Stent System Could Mean Faster Healing Of Arteries And Greatly Reduced Use Of Blood-Thinning Medication 3/18/2014 9:33:13 AM
CeloNova BioSciences Release: New Treatment Option For Women An Alternative To Hysterectomy 3/11/2014 9:05:45 AM
CeloNova BioSciences: Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 12/2/2009 8:28:24 AM
CeloNova BioSciences: Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding 10/14/2009 8:59:35 AM
CeloNova BioSciences: Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres 10/6/2009 10:52:37 AM
New Embolization Technique Using CeloNova BioSciences's Embozene(TM) Color-Advanced Microspheres Offers Better Clinical Outcomes In The Treatment Of Liver Cancer, European Institute of Oncology (EIO) Study 10/6/2009 7:50:52 AM
CeloNova BioSciences: New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal 9/17/2009 9:45:14 AM
CeloNova BioSciences Release: First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform New Color-Coded Embolic with Polyzene(R)-F Coating Enhances Procedural Safety, Efficiency during Treatment of Hypervascularized Tumors and Arteriovenous Malformations 1/2/2009 10:29:06 AM
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 12/16/2008 6:44:18 AM
CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 12/4/2008 9:11:24 AM
12
//-->